Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Category Archives: Marcum MicroCap

The Marcum MicroCap Conference is a forum where publicly traded companies with less than $500 million in market capitalization can network with the investment community. The two-day 2016 conference will include feature presentations by CEOs and CFOs from seven principal industry sectors, expert panels moderated by industry leaders, and the opportunity to meet with management of presenting companies on a one-on-one basis. Marcum is partnered with KCSA Strategic Communications to present this year’s Marcum MicroCap Conference.

NXT-ID, Inc. (NXTD) Starts Presentation at Marcum MicroCap Conference

NXT-ID (NASDAQ: NXTD) is an emerging technology company focused on products, solutions, and services for security on mobile devices. Its core technologies consist of those that support digital payments, biometric identification, encryption, sensors, and miniaturization. The company is pursuing three … Continue reading

Posted in Marcum MicroCap | Leave a comment

Pyxis Tankers, Inc. (PXS) Starts Presentation at Marcum MicroCap Conference

Pyxis Tankers (NASDAQ: PXS) owns a modern fleet of six tankers engaged in the seaborne transportation of refined petroleum products and other bulk liquids. The company is focused on growing its fleet of medium range product tankers, which are designed … Continue reading

Posted in Marcum MicroCap | Leave a comment

Microlin Bio, Inc. (MICBE) Starts Presentation at Marcum MicroCap Conference

Microlin Bio (OTC: MICBE) is an emerging therapeutics company focused on microRNA and its role in oncology. MicroRNAs are recently discovered, naturally occurring RNA molecules that do not encode proteins, but instead regulate gene expression and various biological pathways. Improper … Continue reading

Posted in Marcum MicroCap | Leave a comment

ImmunoCellular Therapeutics, Ltd. (IMUC) Starts Presentation at Marcum MicroCap Conference

ImmunoCellular Therapeutics, Ltd. (NYSE: IMUC) is a Los Angeles-based clinical-stage company developing immune-based therapies for the treatment of brain and other cancers. The company has concluded a phase II trial of its lead product candidate, ICT-107, a dendritic cell-based vaccine … Continue reading

Posted in Marcum MicroCap | Leave a comment

eWellness Healthcare Corp. (EWLL) Starts Presentation at Marcum MicroCap Conference

eWellness Healthcare (OTC: EWLL) is the first physical therapy telemedicine company to offer real-time, insurance reimbursable distance monitored treatments. The company’s business model is to license its PHZIO (“PHZIO”) platform to any physical therapy clinic in the U.S. and/or have large-scale … Continue reading

Posted in Marcum MicroCap | Leave a comment

AstroNova, Inc. (ALOT) Starts Presentation at Marcum MicroCap Conference

Astro-Med, Inc., d/b/a AstroNova (NASDAQ: ALOT) designs, manufactures, distributes and services a broad range of products that acquire, store, analyze and present data in multiple formats. The company’s Product Identification segment offers a variety of hardware and software products and … Continue reading

Posted in Marcum MicroCap | Leave a comment

PeerLogix, Inc. (LOGX) Starts Presentation at Marcum MicroCap Conference

PeerLogix (OTC: LOGX) is a data aggregation company using proprietary software to enable the tracking and cataloguing of Torrent files and Torrent networks to determine consumer trends and preferences based upon media consumption. PeerLogix’s patent pending platform collects Torrent data, … Continue reading

Posted in Marcum MicroCap | Leave a comment

Bridgeline Digital, Inc. (BLIN) Starts Presentation at Marcum MicroCap Conference

As The Digital Engagement Company™, Bridgeline Digital’s (NASDAQ: BLIN) strategy is to help customers maximize the performance of their full digital experience – from websites and intranets to online stores and campaigns. The company’s iAPPS platform deeply integrates web content … Continue reading

Posted in Marcum MicroCap | Leave a comment

Soligenix, Inc. (SNGX) Starts Presentation at Marcum MicroCap Conference

Soligenix (OTC: SNGX) is a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need. The company has two active business segments. The BioTherapeutics segment is developing a photo-dynamic therapy … Continue reading

Posted in Marcum MicroCap | Leave a comment

PURE Bioscience, Inc. (PURE) Starts Presentation at Marcum MicroCap Conference

PURE Bioscience (OTC: PURE) is commercializing its patented antimicrobial products (FDA-approved PURE Control® and EPA registered PURE® Hard Surface) providing less toxic and more effective food safety solutions for food processors/manufacturers, retailers and restaurants. Test data demonstrate PURE’s products’ superior … Continue reading

Posted in Marcum MicroCap | Leave a comment